
Larimar Therapeutics Inc (LRMR) Stock: Analyzing the Market Value
The 36-month beta value for LRMR is at 0.87. Analysts have varying views on the stock, with 10 analysts rating it as a “buy,” 2
The 36-month beta value for LRMR is at 0.87. Analysts have varying views on the stock, with 10 analysts rating it as a “buy,” 2
In the past week, LRMR stock has gone up by 17.26%, with a monthly gain of 23.26% and a quarterly plunge of -28.57%. The volatility
The stock of Larimar Therapeutics Inc (LRMR) has gone up by 27.27% for the week, with a -6.30% drop in the past month and a
The stock of Larimar Therapeutics Inc (LRMR) has seen a -2.22% decrease in the past week, with a -21.15% drop in the past month, and
Larimar Therapeutics Inc (NASDAQ: LRMR)’s stock price has decreased by -10.24 compared to its previous closing price of 2.54. However, the company has seen a
Larimar Therapeutics Inc (NASDAQ: LRMR)’s stock price has plunge by 8.44relation to previous closing price of 2.37. Nevertheless, the company has seen a -4.46% plunge
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.